# MEDICINES CO /DE

MEDICINES CO /DE is a company headquartered in Parsippany, NJ, United States.

## Company overview

- **Legal name:** MEDICINES CO /DE
- **Former names in filing history:** MEDICINES CO/ MA (2000-08-31 to 2003-02-14)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Parsippany, NJ, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001113481

## About

MEDICINES CO /DE is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001113481, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2019-02-27, it reported annual revenue of USD 6,138,000; net income of USD -123,156,000; total assets of USD 841,686,000 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-12-31)

- **Revenue:** $6.1M (USD 6,138,000)
- **Net income:** -$123.2M (USD -123,156,000)
- **Total assets:** $841.7M (USD 841,686,000)
- **Cash and equivalents:** $238.3M (USD 238,310,000)
- **Operating cash flow:** -$261.8M (USD -261,795,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $44.8M (USD 44,789,000)
- **Net income:** -$708.4M (USD -708,373,000)
- **Total assets:** $873.0M (USD 872,983,000)
- **Cash and equivalents:** $151.4M (USD 151,359,000)
- **Operating cash flow:** -$368.3M (USD -368,288,000)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $167.8M (USD 167,835,000)
- **Net income:** -$119.1M (USD -119,118,000)
- **Total assets:** $1.7B (USD 1,705,211,000)
- **Cash and equivalents:** $541.8M (USD 541,835,000)
- **Operating cash flow:** -$323.3M (USD -323,309,000)
- **Later filings:** Revenue: shown as originally filed; later filings report different values for the same periods.

### FY2015 (period ended 2015-12-31)

- **Revenue:** $309.0M (USD 309,007,000)
- **Net income:** -$352.8M (USD -352,756,000)
- **Total assets:** $1.8B (USD 1,806,951,000)
- **Cash and equivalents:** $373.2M (USD 373,173,000)
- **Operating cash flow:** -$198.0M (USD -197,965,000)
- **Later filings:** Revenue, Total assets: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2020-01-06 — period 2020-01-06 — FORM 8-K
- Form 8-K — filed 2020-01-06 — period 2020-01-06 — FORM 8-K
- Form 8-K — filed 2019-11-25 — period 2019-11-23 — FORM 8-K
- Form 10-Q — filed 2019-10-30 — period 2019-09-30 — 10-Q
- Form 8-K — filed 2019-10-30 — period 2019-10-30 — 8-K
- Form 10-Q — filed 2019-07-24 — period 2019-06-30 — 10-Q
- Form 8-K — filed 2019-07-24 — period 2019-07-24 — 8-K
- Form 8-K — filed 2019-06-28 — period 2019-06-24 — FORM 8-K
- Form 8-K — filed 2019-06-05 — period 2019-05-30 — 8-K
- Form SC 13D — filed 2019-05-30 — SCHEDULE 13D
- Form DEF 14A — filed 2019-04-29 — period 2019-04-29 — DEF 14A
- Form 10-Q — filed 2019-04-26 — period 2019-03-31 — 10-Q

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/medicines-co-de

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology